<?xml version="1.0" encoding="UTF-8"?>
<p>The therapeutic drugs mentioned in the interim guidelines for COVID-19 treatment (
 <xref rid="jcm-09-02084-t001" ref-type="table">Table 1</xref>) were also selected for the SOLIDARITY trial: remdesivir (RDV), an experimental antiviral; chloroquine (CQ), an antimalarial agent (or hydroxychloroquineâ€”HCQ); a combination of lopinavir and ritonavir (LPV/r), an anti-HIV medication; and lopinavir + ritonavir + interferon-beta (an antiviral and modulator of the immune system that acts by suppressing pro-inflammatory cytokines) (see 
 <xref rid="jcm-09-02084-t002" ref-type="table">Table 2</xref>) [
 <xref rid="B56-jcm-09-02084" ref-type="bibr">56</xref>].
</p>
